Oncological applications of FDG PET imaging: brain tumors, colorectal cancer, lymphoma and melanoma.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 10210218.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
This article will focus primarily on body oncology diagnosis, staging and therapy monitoring using fluorodeoxyglucose (FDG) PET imaging. Common pitfalls and artifacts in body FDG imaging will be covered. Examples of diagnosis, staging and therapy monitoring of brain tumor, colorectal cancer, lymphoma and melanoma will be given. Importance of correlation with anatomic imaging and practical use of FDG imaging in patient management will be stressed.
Medical subject headings
- Brain Neoplasms
- Colorectal Neoplasms
- Fluorodeoxyglucose F18
- Lymphoma
- Melanoma
- Tomography, Emission-Computed